Intensive care for patients with gastric cancers: outcome and survival prognostic factors.
Gastric cancer
intensive care
intubation
metastatic
outcome
prognostic
Journal
Journal of gastrointestinal oncology
ISSN: 2078-6891
Titre abrégé: J Gastrointest Oncol
Pays: China
ID NLM: 101557751
Informations de publication
Date de publication:
Apr 2019
Apr 2019
Historique:
entrez:
30
4
2019
pubmed:
30
4
2019
medline:
30
4
2019
Statut:
ppublish
Résumé
Admission and management of patients with solid malignancies in intensive care unit (ICU) is a controversial topic. To this day, there is no data published concerning patients with gastric cancers hospitalized in ICU. This single center retrospective study reports the characteristics, outcome and prognostic factors of patients hospitalized in ICU for medical reasons over a period of 10 years. We performed a single center retrospective study which reports the characteristics, outcome and prognostic factors of patients hospitalized in ICU for medical reasons over a period of 10 years. Thirty-seven patients were included, among whom 24 (64.9%) had metastatic cancer. The most frequent diagnosis on admission was septic shock (48.6%) and 24 patients (64.9%) required intubation. Ten patients (27.0%) were alive 3 months after their admission in ICU. Metastatic cancer and intubation were independently associated with a higher risk of dying within 3 months of admission in multivariate analysis: odds ratio (OR) =13.7; 95% confidence interval (CI), 1.7-108 (P<0.01). Seventeen patients (45.9%) died during their ICU stay. Metastatic cancer: OR =89; 95% CI, 2.7-6,588, therapeutic intensification: OR =1,471; 95% CI, 9.8-811,973 and the logistic organ dysfunction score (LODS) on admission: OR =1.4; 95% CI, 1.1-2.3 were independently associated with mortality within the ICU in multivariate analysis (P<0.01). This is the first study that examines the outcome and prognostic factors of patients with gastric cancers who require life-sustaining therapy in ICU. The identification of 3 months and ICU mortality prognostic factors could contribute to guiding clinicians in the management of these patients and assist health professionals in their discussions with these patients and their families.
Sections du résumé
BACKGROUND
BACKGROUND
Admission and management of patients with solid malignancies in intensive care unit (ICU) is a controversial topic. To this day, there is no data published concerning patients with gastric cancers hospitalized in ICU. This single center retrospective study reports the characteristics, outcome and prognostic factors of patients hospitalized in ICU for medical reasons over a period of 10 years.
METHODS
METHODS
We performed a single center retrospective study which reports the characteristics, outcome and prognostic factors of patients hospitalized in ICU for medical reasons over a period of 10 years.
RESULTS
RESULTS
Thirty-seven patients were included, among whom 24 (64.9%) had metastatic cancer. The most frequent diagnosis on admission was septic shock (48.6%) and 24 patients (64.9%) required intubation. Ten patients (27.0%) were alive 3 months after their admission in ICU. Metastatic cancer and intubation were independently associated with a higher risk of dying within 3 months of admission in multivariate analysis: odds ratio (OR) =13.7; 95% confidence interval (CI), 1.7-108 (P<0.01). Seventeen patients (45.9%) died during their ICU stay. Metastatic cancer: OR =89; 95% CI, 2.7-6,588, therapeutic intensification: OR =1,471; 95% CI, 9.8-811,973 and the logistic organ dysfunction score (LODS) on admission: OR =1.4; 95% CI, 1.1-2.3 were independently associated with mortality within the ICU in multivariate analysis (P<0.01).
CONCLUSIONS
CONCLUSIONS
This is the first study that examines the outcome and prognostic factors of patients with gastric cancers who require life-sustaining therapy in ICU. The identification of 3 months and ICU mortality prognostic factors could contribute to guiding clinicians in the management of these patients and assist health professionals in their discussions with these patients and their families.
Identifiants
pubmed: 31032097
doi: 10.21037/jgo.2018.10.11
pii: jgo-10-02-292
pmc: PMC6465480
doi:
Types de publication
Journal Article
Langues
eng
Pagination
292-299Déclaration de conflit d'intérêts
Conflicts of Interest: The authors have no conflicts of interest to declare.
Références
Mayo Clin Proc. 1992 Feb;67(2):117-22
pubmed: 1545573
Chest. 2006 Sep;130(3):719-23
pubmed: 16963668
Crit Care Med. 2007 Mar;35(3):808-14
pubmed: 17235261
Chest. 2007 Mar;131(3):840-846
pubmed: 17356101
Ann Oncol. 2008 Nov;19(11):1882-7
pubmed: 18669868
Crit Care. 2009;13(1):R15
pubmed: 19200368
J Clin Oncol. 2009 Aug 10;27(23):3786-93
pubmed: 19398575
Ann Oncol. 2009 Sep;20(9):1529-34
pubmed: 19474114
Lancet. 2010 Aug 28;376(9742):687-97
pubmed: 20728210
Asian Pac J Cancer Prev. 2012;13(1):97-101
pubmed: 22502721
Ann Oncol. 2015 Jan;26(1):149-56
pubmed: 25416687
CA Cancer J Clin. 2015 Mar;65(2):87-108
pubmed: 25651787
Lancet Oncol. 2016 Dec;17(12):1697-1708
pubmed: 27776843
ESMO Open. 2016 Sep 13;1(5):e000018
pubmed: 27843637
Lancet Oncol. 2017 Jun;18(6):e307
pubmed: 28483410
Crit Care Resusc. 2017 Jun;19(2):159-166
pubmed: 28651512
JAMA. 1996 Sep 11;276(10):802-10
pubmed: 8769590
Am J Respir Crit Care Med. 1998 Sep;158(3):876-84
pubmed: 9731020